Pelletier Nadege 4
4 · Vaccitech plc · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Vaccitech plcVACC
Pelletier Nadege
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2023-02-01+485,000→ 485,000 totalExercise: $2.90Exp: 2033-02-01→ Ordinary Shares (485,000 underlying)
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 1, 2024.